Elutia Inc
NASDAQ:ELUT

Watchlist Manager
Elutia Inc Logo
Elutia Inc
NASDAQ:ELUT
Watchlist
Price: 2.33 USD 7.37% Market Closed
Market Cap: 95.2m USD

Wall Street
Price Targets

ELUT Price Targets Summary
Elutia Inc

Wall Street analysts forecast ELUT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELUT is 9.18 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

Lowest
Price Target
8.08 USD
247% Upside
Average
Price Target
9.18 USD
294% Upside
Highest
Price Target
10.5 USD
351% Upside
Elutia Inc Competitors:
Price Targets
397030
AprilBio Co Ltd
119% Upside
600201
Jinyu Bio-Technology Co Ltd
16% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
36% Upside
AMGN
Amgen Inc
17% Upside
APGE
Apogee Therapeutics Inc
159% Upside
VRTX
Vertex Pharmaceuticals Inc
4% Upside
ALNY
Alnylam Pharmaceuticals Inc
29% Upside
HALO
Halozyme Therapeutics Inc
17% Upside

Revenue
Forecast

Revenue Estimate
Elutia Inc

For the last 5 years the compound annual growth rate for Elutia Inc's revenue is -11%. The projected CAGR for the next 2 years is 50%.

-11%
Past Growth
50%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Elutia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Elutia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELUT's stock price target?
Price Target
9.18 USD

According to Wall Street analysts, the average 1-year price target for ELUT is 9.18 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

What is Elutia Inc's Revenue forecast?
Projected CAGR
50%

For the last 5 years the compound annual growth rate for Elutia Inc's revenue is -11%. The projected CAGR for the next 2 years is 50%.

Back to Top